Joanne Kennedy, RN

Massachusetts General HospitalBoston, Massachusetts - 02114 |
- CLINICAL TRIALS 5
- CONDITIONS19
- INTERVENTIONS22
- SINCE2001

Reduced Intensity Conditioning With Clofarabine Antithymocyte Globulin (ATG) Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant
June 2008 - June 2011

Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
August 2001 - August 2013

Sequential Myeloablative Autologous Stem Cell Transplantation Followed by Allogeneic Non-Myeloablative Stem Cell Transplantation for Patients With Poor Risk Lymphomas
August 2010 - August 2015

Tacrolimus/Sirolimus/Methotrexate Versus Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma
June 2009 - June 2014

Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma
April 2005 - September 2011
Lymphoma
Lymphoma, Non-Hodgkin
Kidney Diseases
Kidney Failure, Chronic
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Myelodysplastic Syndromes
Preleukemia
Lymphoma, T-Cell
Hodgkin Disease
Lymphoma, Large B-Cell, Diffuse
Lymphoma, Mantle-Cell
Kidney Failure
Fludarabine
Busulfan
Cyclophosphamide
Cyclosporine
Methotrexate
Tacrolimus
Mycophenolate Mofetil
Etoposide
Mesna
Ursodiol
Neupogen
Sirolimus
Clofarabine
Antithymocyte Globulin
Phenytoin
Cyclophosphamide, Anti-Thymocyte Globulin, Cyclosporine
Kidney Transplant
Thymic Irradiation
Bone Marrow Transplant From A Related Donor
Infusion Of Autologous Peripheral Blood Stem Cells
Peripheral Blood Stem Cell Transplant
Dendritic Cell Tumor Fusion



